TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Verto Pharma AB
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,147
|
2,326
|
1,563 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
495
|
1,208
|
594 |
| EBITDA |
504
|
1,225
|
604 |
| Total assets |
5,641
|
5,338
|
4,607 |
| Current assets |
3,257
|
2,868
|
1,974 |
| Current liabilities |
1,173
|
754
|
423 |
| Equity capital |
4,249
|
4,323
|
3,934 |
| - share capital |
47
|
49
|
52 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
75.3%
|
81.0%
|
85.4% |
| Turnover per employee |
1,147
|
2,326
|
1,563 |
| Profit as a percentage of turnover |
43.2%
|
51.9%
|
38.0% |
| Return on assets (ROA) |
8.8%
|
22.6%
|
12.9% |
| Current ratio |
277.7%
|
380.4%
|
466.7% |
| Return on equity (ROE) |
11.6%
|
27.9%
|
15.1% |
| Change turnover |
-1,109
|
871
|
1,267 |
| Change turnover % |
-49%
|
60%
|
427% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.